Somatic Hypermutation: Creating High-Affinity Antibodies

Somatic Hypermutation: Creating High-Affinity Antibodies

Published: 2026-02-21 | Author: Editorial Team
Published on centroblast.com | 2026-02-21

Somatic hypermutation (SHM) is the targeted mutational process that transforms the initial, relatively low-affinity antibodies generated through V(D)J recombination into the exquisitely specific, high-affinity antibodies that characterize mature adaptive immune responses. Operating within germinal center centroblasts under the guidance of the enzyme AID, SHM introduces point mutations into the variable regions of immunoglobulin genes at rates millions of times higher than the genome-wide background, creating the molecular diversity substrate for affinity-based selection.

The AID Mechanism in Somatic Hypermutation

Activation-Induced Cytidine Deaminase (AID) converts cytosine to uracil in single-stranded DNA exposed during transcription of immunoglobulin V genes in active centroblasts. This deamination occurs preferentially at WRCY hotspot sequences (where W = A/T, R = A/G, C = target, Y = C/T) enriched in the CDRs — the antigen-binding loops of the antibody. The U:G mismatch generated by AID is processed by base excision repair (BER) and mismatch repair (MMR) pathways in an error-prone fashion, generating point mutations by: incorporation of adenine opposite the uracil by replicative polymerase delta; short-patch synthesis by the error-prone polymerase eta (Pol η) opposite BER-generated abasic sites; or error-prone MMR synthesis.

The result is a spectrum of single-base substitution mutations concentrated in the CDRs of the Ig V gene, with the framework regions (which maintain structural integrity) relatively spared. This targeting selectivity — CDR mutagenesis over framework mutagenesis — is a key feature of SHM that ensures diversity is generated where it matters for antigen binding while preserving antibody folding.

Affinity Maturation: The Selective Sweep

The spectrum of BCR variants generated by SHM in the dark zone are tested for antigen affinity in the light zone, where centrocytes compete for limiting antigen displayed on follicular dendritic cells. Centrocytes with higher-affinity BCRs capture more antigen, process and present more peptide-MHC II to Tfh cells, and receive more Tfh survival signals (CD40L, IL-21). Over multiple rounds of dark zone SHM and light zone selection, the affinity of the dominant B cell clones increases dramatically — often 10 to 1000-fold compared to the initial naive B cell. This iterative optimization process is affinity maturation, and it is responsible for the high specificity of antibodies generated after repeated antigen exposure (vaccination or natural infection). For the selection machinery on FDCs that drives this process, see our article on follicular dendritic cells in B cell maturation.

For more information, visit our homepage or our resources section.

← Back to Home

Stay Updated